Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding Phreesia’s patient-volume metrics or HIPAA compliance costs inside a 250-page filing can slow any analyst. Healthcare SaaS companies combine software revenue rules with healthcare regulations, making disclosures tough to parse. That’s why Stock Titan’s AI deciphers Phreesia SEC filings explained simply—turning dense accounting notes and regulatory risk sections into plain-language highlights.
Need to spot how subscription renewals trend across medical groups in the latest Phreesia quarterly earnings report 10-Q filing? Curious whether executives trimmed holdings before a product launch? Our platform links each disclosure to what matters for this business: 10-Ks outline retention rates and payment-processing margins, 8-K material events explained show new EHR partnerships, and every proxy statement executive compensation details incentive plans aligned with patient engagement growth. Meanwhile, real-time alerts surface Phreesia insider trading Form 4 transactions the moment they hit EDGAR, so you can monitor executive stock transactions Form 4 without refreshing the site.
Here’s how professionals use these insights: compare segment revenue across consecutive reports, track Form 4 insider transactions real-time to gauge leadership sentiment, and export AI summaries to brief stakeholders faster than manual review. Whether you’re understanding Phreesia SEC documents with AI for diligence, or need a Phreesia annual report 10-K simplified for board decks, Stock Titan keeps you current—complete coverage, automatic updates, and AI-driven earnings report filing analysis in one place.
Capital International Investors reports beneficial ownership of 3,134,872 shares of Phreesia, Inc., representing 5.3% of the approximately 59,504,269 shares outstanding. The filing states that CII, a division of Capital Research and Management Company and its investment management affiliates, is deemed the beneficial owner through its investment management entities.
The filing indicates CII holds sole voting and sole dispositive power over these shares and includes a certification that the securities are held in the ordinary course of business and not to influence control. The filing also names SMALLCAP World Fund, Inc. in connection with ownership on behalf of another person.
Champlain Investment Partners, LLC reported a Schedule 13G disclosing a passive stake in Phreesia, Inc. The firm beneficially owns 2,724,553 shares, equal to 4.6% of the outstanding class. Champlain reports sole dispositive power over all 2,724,553 shares and sole voting power over 1,742,028 shares, with no shared voting or dispositive power. The filing identifies the reporting person as an investment adviser and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
